MedTrace Logo

Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children

NCT06697522 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2024-11-20

No results posted yet for this study

Summary

This study is a randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of atropine sulfate eye drops (0.01%) in treating transient myopia induced by near work tasks (NITM) in pediatric subjects.

Conditions

  • Myopia

Interventions

DRUG

Atropine Sulfate

low concentration atropine (0.01%)

DRUG

Placebo

Blank comparator

Sponsors & Collaborators

  • Beijing Children's Hospital

    collaborator OTHER

  • Ocumension Therapeutics (Suzhou) Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Xiaoling Wang · Beijing Children's Hospital

  • Li Li · Beijing Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-25
Primary Completion
2023-10-06
Completion
2024-03-26

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06697522 on ClinicalTrials.gov